Interleukin-23 (IL-23) plays a pivotal role in the complex pathogenesis of both ulcerative colitis and Crohn's disease, making it a promising therapeutic target.1 Mirikizumab is a humanised IgG4 ...
Earlier reports blamed several medications including nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs), selective serotonin reuptake inhibitors (SSRIs), statins, and ...
A new study indicates a common genetic variant may interact with gut bacteria to trigger chronic inflammation in ulcerative colitis. The findings may help explain why people experience the disease ...
Inflammatory Bowel Disease affects more than 100,000 young people under the age of 20. Crohn's and Colitis are the two most common forms of IBD. "The classic symptoms include diarrhea, blood in the ...
The US Food and Drug Administration (FDA) has approved Skyrizi (risankizumab-rzaa; AbbVie) for the treatment of moderately to severely active ulcerative colitis in adults. This approval makes it the ...
Fifteen isolates of Clostridium difficile from hamsters and human patients were inhibited or killed by low concentrations of metronidazole, vancomycin, penicillin, and ampicillin; the isolates were ...
Stress is an inevitable part of life, but it can impact everyone differently. In patients with ulcerative colitis, stress is a trigger that can lead to flares and worsening symptoms. That means ...
For decades, scientists have puzzled over why smoking makes Crohn’s disease worse but seems to protect people from ulcerative colitis. Now, researchers at RIKEN have discovered that smoking creates ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Ulcerative Colitis Market and Forecast Analysis" report to their offering. Ulcerative colitis is a chronic inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback